Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Uncover where to find the best online coupon deals. This guide will help you save big on your next purchases.
14,209 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
FuelCell Energy surges on a major data-center deal, while Bloom Energy retreats, underscoring a rare divergence in th...
When public attention shines on young earners, smart financial habits can turn a brief spotlight into lasting wealth....
Investors are racing to price in the first real revenue opportunities from quantum tech as a new federal funding push...
Ripple unveils a day-one Open USD partnership as XRP hovers near $1, with RLUSD clearing regulatory hurdles and insti...
As AI moves from experiments to real workloads, the need for secure, low-latency data paths grows. This look explores...
Could canopy growth stock realistically quadruple from here? This deep-dive walks through the bull case, the risks, a...
Microsoft cutting 4,800 jobs marks a bold pivot toward AI and cloud infrastructure. The move comes with a hefty capex...
A USMCA review is on the radar as supply chains evolve and tariffs shift. This article breaks down why extending the ...
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Rising defense budgets are reshaping the investing landscape. This guide explains why two big players may benefit and...